How major US stock indexes fared Wednesday

Associated Press |

Global stock indexes sank Wednesday after the Trump administration released a list of $200 billion in goods that could be hit with tariffs and China said it would retaliate. The dollar spiked and big exporters plunged.

On Wednesday:

The S&P 500 index slid 19.82 points, or 0.7 percent, to 2,774.02.

The Dow Jones Industrial Average retreated 219.21 points, or 0.9 percent, to 24,700.75.

The Nasdaq composite skidded 42.59 points, or 0.5 percent, to 7,716.61.

The Russell 2000 index of smaller companies dipped 11.96 points, or 0.7 percent, to 1,683.66.

For the week:

The S&P 500 is up 14.20 points, or 0.5 percent.

The Dow is up 243.97 points, or 1 percent.

The Nasdaq is up 28.22 points, or 0.4 percent.

The Russell 2000 is down 10.39 points, or 0.6 percent.

For the year:

The S&P 500 is up 100.41 points, or 3.8 percent.

The Dow is down 18.77 points, or 0.1 percent.

The Nasdaq is up 813.22 points, or 11.8 percent.

The Russell 2000 is up 148.15 points, or 9.6 percent.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor, Equities.com; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.